🇺🇸 FDA
Pipeline program

E0302 (mecobalamin)

E0302-J081-761

Phase 3 small_molecule completed

Quick answer

E0302 (mecobalamin) for Amyotrophic Lateral Sclerosis (ALS) is a Phase 3 program (small_molecule) at Eisai Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Eisai Co.,
Indication
Amyotrophic Lateral Sclerosis (ALS)
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials